Consistent with a previous study [16], the frequency of CD14+HLA-DR−/low MDSC in blood was markedly increased in psoriasis patients when compared to healthy control subjects, yet there was no statistically significant relationship with disease severity (based on the PASI score). This evidence concerns the gene CD14 and psoriasis.